Supplementary Figures 1 - 6 from microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters
Massimo Negrini(University of Ferrara), Antonino Neri(University of Milan), Luca Agnelli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Massimo Gentile(Azienda Ospedaliera di Cosenza), Fortunato Morabito(Azienda Ospedaliera di Cosenza), Manuela Ferracin(University of Ferrara), Elena Saccenti(University of Ferrara), Manlio Ferrarini(North Shore University Hospital), Gian Matteo Rigolin, Monica Colombo(Ospedale Policlinico San Martino), Serena Matis(Ospedale Policlinico San Martino), Giandomenico Russo(Istituto Dermopatico dell'Immacolata), Sabrina Bossio(Consejo Nacional de Investigaciones Científicas y Técnicas), Marta Lionetti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Daniele Reverberi(Ospedale Policlinico San Martino), Sonia Fabris(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Lucilla D’Abundo(University of Ferrara), Anna Grazia Recchia(Azienda Ospedaliera di Cosenza), Barbara Zagatti(University of Ferrara), Pierfrancesco Tassone(Magna Graecia University), Silvia Sabbioni(University of Ferrara), Cristian Bassi(University of Ferrara), George A. Calin(The University of Texas MD Anderson Cancer Center), Giovanna Cutrona(Ospedale Policlinico San Martino)
Cited by 0
Related Papers
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
|Journal of Experimental & Clinical Cancer Research|2020|270
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
|Leukemia|2018|247
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement
|Clinical & Experimental Immunology|2004|230